News

Regulatory expectations from MAHs during COVID-19

Published: 24/9/2020

Q&A about regulatory expectations for medicinal products for human use during the COVID19 pandemic.

MHRA post-transition period information

Published: 24/9/2020

More Information and guidance concerning MHRA post-transition period for industries and organisations.

Registering new packaging information for medicines in UK

Published: 8/9/2020

New guideline for registering new packaging information for medicines in UK from 1 January, 2021 and update on UK QPPV plus PSMF.

On-site GxP Inspection Programme

Published: 28/8/2020

Guidance for industry on MHRA's expectations for return to UK on-site inspections

Nitrosamine Impurities

Published: 28/8/2020

Marketing Authorisation Holders' submission of nitrosamine risk evaluation

Safe Labelling of Excipients in Medicines

Published: 20/7/2020

Deadline is approaching.

Guidance for medicine developers and companies on COVID-19

Published: 29/6/2020

EMA encourages medicine developers and pharmaceutical companies who are working on medications and vaccines in regard to COVID-19

Stakeholders: Regulatory expectations during COVID-19 pandemic

Published: 29/6/2020

How COVID-19 is affecting my GMP/GDP licence when renewal is approaching

EMA recommended granting conditional MA to Remdesivir

Published: 29/6/2020

Seems that first approved COVID treatment will go through registration

Brexit in pharma

Published: 4/10/2018

EMA and MHRA published Brexit Preparedness Business Continuity Plan, ready to address all challenges for your business

EUPV essential and challenges

Published: 4/10/2018

Fom pharmacovigilance contracts to daily routine PV activities with obligation reports .

Ready for pharmacovigilance inspection

Published: 4/10/2018

USFDA recent campaign of focus PV inspection in Asia, main challenges in social media.

Serialisation

Published: 4/10/2018

Driving business value from pharmaceutical serialisation, challenges you will be facing – strategic advice as well as pragmatic solution

Certified Centre of Excellence

Published: 10/8/2018

VergoResearch & Pharmazet at CPHI join venture

NEW entry to OTC

Published: 10/8/2018

Pharmazet Group is pleased to registration of first set of own products in OTC range as per our plans to enter to OTC market within CEE region.

GET IN TOUCH!